PT-141
$49
PT-141 (Bremelanotide) is a melanocortin receptor agonist studied for its activity within central nervous system pathways. Commonly used exploring neuroendocrine signaling and receptor-mediated response models. Sexual health research for both men and women.
PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist originally developed from the melanotan peptide family. Unlike compounds that primarily act through vascular pathways, PT-141 is studied for its interaction with the central nervous system, particularly melanocortin receptors involved in behavioral and neurological signaling.
In research settings, PT-141 has been explored for its potential influence on motivation, arousal pathways, and neuroendocrine signaling. Because it operates centrally rather than peripherally, it has drawn attention in laboratory studies focused on receptor-mediated response mechanisms.
Researchers value PT-141 for:
-
Melanocortin receptor activity (MC3R/MC4R)
-
CNS pathway interaction
-
Neuroendocrine signaling
-
Behavioral and response modulation models